Advertisement
Singapore markets closed
  • Straits Times Index

    3,499.89
    +2.11 (+0.06%)
     
  • S&P 500

    5,643.05
    +27.70 (+0.49%)
     
  • Dow

    40,178.60
    +177.70 (+0.44%)
     
  • Nasdaq

    18,535.74
    +137.29 (+0.75%)
     
  • Bitcoin USD

    62,934.89
    +3,192.12 (+5.34%)
     
  • CMC Crypto 200

    1,308.45
    +39.50 (+3.11%)
     
  • FTSE 100

    8,179.96
    -72.95 (-0.88%)
     
  • Gold

    2,423.50
    +2.80 (+0.12%)
     
  • Crude Oil

    81.81
    -0.40 (-0.49%)
     
  • 10-Yr Bond

    4.2260
    +0.0370 (+0.88%)
     
  • Nikkei

    41,190.68
    -1,033.32 (-2.45%)
     
  • Hang Seng

    18,015.94
    -277.44 (-1.52%)
     
  • FTSE Bursa Malaysia

    1,629.82
    +10.76 (+0.66%)
     
  • Jakarta Composite Index

    7,278.86
    -48.72 (-0.66%)
     
  • PSE Index

    6,689.37
    +41.14 (+0.62%)
     

Bristol Myers Squibb Announces Dividend

PRINCETON, N.J., June 18, 2024--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company. The dividend is payable on August 1, 2024, to stockholders of record at the close of business on July 5, 2024.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on September 3, 2024, to stockholders of record at the close of business on August 6, 2024.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and Instagram.

ADVERTISEMENT

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20240618367820/en/

Contacts

For more information, contact:

Media:
media@bms.com

Investors:
investor.relations@bms.com